Institutional Ownership
Sangamo Therapeutics Inc
CUSIP 800677106COMSGMOQ1 2026
13D / 13G Filings
31
Schedule 13D/13G on record
Beneficial Filers
8
Distinct reporting persons
Largest Stake
17.4%
Max % of class reported
Institutional Holders
108
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
31 filings · latest Nov 12, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Nov 12, 2025 | Wasatch Advisors LP | 13G/A | 2.1% | 6.19M | SEC |
| 2 | May 12, 2025 | Wasatch Advisors LP | 13G/A | 5.2% | 11.63M | SEC |
| 3 | Jan 7, 2025 | Wasatch Advisors LP | 13G/A | 6.6% | 13.99M | SEC |
| 4 | Nov 12, 2024 | Vanguard Group Inc | 13G/A | 4.6% | 9.60M | SEC |
| 5 | Nov 4, 2024 | Vanguard Group Inc | 13G/A | 4.6% | 9.60M | SEC |
| 6 | Aug 16, 2024 | Biogen Inc. | 13G/A | 1.6% | 3.25M | SEC |
| 7 | Jul 8, 2024 | Blackrock Inc. | 13G/A | 2.3% | 4.70M | SEC |
| 8 | Apr 5, 2024 | Wasatch Advisors LP | 13G/A | 11.9% | — | SEC |
| 9 | Feb 13, 2024 | Vanguard Group Inc | 13G/A | 7.1% | 12.60M | SEC |
| 10 | Feb 12, 2024 | Biogen Inc. | 13G/A | 8.3% | 14.65M | SEC |
21 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Sangamo Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Armistice Capital, LLC | 40.40M | $9.97M |
| 2 | Two Sigma Investments, LP | 6.27M | $1.55M |
| 3 | Balyasny Asset Management L.P. | 5.29M | $1.31M |
| 4 | Geode Capital Management, LLC | 4.57M | $1.13M |
| 5 | Blackrock, Inc. | 4.55M | $1.12M |
| 6 | Renaissance Technologies LLC | 3.84M | $947.3K |
| 7 | Ubs Group AG | 2.57M | $635.0K |
| 8 | Charles Schwab Investment Management Inc | 2.35M | $580.8K |
| 9 | Jacobs Levy Equity Management, Inc | 2.05M | $506.2K |
| 10 | Bank Of America Corp /De/ | 1.84M | $452.2K |